SEREDA, Y.,
KIRIAZOVA, T.,
MAKARENKO, O.,
CARROLL, J.J.,
RYBAK, N.,
GILLANI, F.S.,
FLANIGAN, T.,
CHYBISOV, A.,
BENDIKS, S.,
DUTTA, A.,
SAMET, J.H.,
LUNZE, K.,
IDRISOV, B. (2020) in Ukraine during July-September, 2017.
Primary outcomes were HIV stigma (Berger scale), substance use stigma
CHROMCHENKOVA, E.P.,
BOKOV, D.O.,
BESSONOV, V.V.,
SAMYLINA, I.A.,
KAKHRAMANOVA, S.D.,
CHEVIDAEV, V.V.,
SOKHIN, D.M.,
BALOBANOVA, N.P.,
EVGRAFOV, A.A.,
KRASNYUK, J.I.,
KUDASHKINA, N.V.,
GALIAKHMETOVA, E.K.,
MARAKHOVA, A.I.,
MOISEEV, D.V. (2020) of
primary amines) and with fluorenylmethyloxycarbonyl (FMOC) (secondary amines). The sources of scientific
YANG, G.,
SUN, J.,
ZHANG, D.,
ZHANG, R.,
ZHONG, Y.,
WANG, X.,
CHEN, X.,
LIU, B.,
LI, L.,
ZHAO, S.,
WANG, L.,
YUAN, C.,
LONG, M.,
JIANG, H.,
LI, C.,
ZHOU, Q.,
LIAN, A.,
GAREEV, I. (2020) conducted a retrospective study on 364 acute ICH patients from January to December 2016. The
primary outcome